Skip to main content

Table 2 Autophagy-related markers in combination hepatocellular carcinoma and cholangiocarcinoma

From: Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection

  Total (n = 40) Non-mortality (n = 25) Mortality (n = 15) P-value Non-recurrence Recurrence P-value
LC3 in tumors
 Low 7 (17.5) 1 (4.0) 6 (40.0) 0.004 2 (6.7) 5 (50.0) 0.002
 High 33 (82.5) 24 (96.0) 9 (60.0)   28 (93.3) 5 (50.0)  
Beclin-1 in tumors
 Low 15 (37.5) 7 (28.0) 8 (53.3) 0.109 9 (30.0) 6 (60.0) 0.09
 High 25 (62.5) 18 (72.0) 7 (46.7)   21 (70.0) 4 (40.0)  
p62 in tumors
 Low 13 (32.5) 10 (40.0) 3 (20.0) 0.191 21 (70.0) 8 (80.0) 0.54
 High 27 (76.5) 15 (60.0) 12 (80.0)   9 (30.0) 2 (20.0)  
LC3 in ANT
 Low 15 (37.5) 9 (36.0) 6 (40.0) 0.8 10 (33.3) 5 (50.0) 0.346
 High 25 (62.5) 16 (64.0) 9 (60.0)   20 (66.7) 5 (50.0)  
Beclin-1 in ANT
 Low 17 (42.5) 10 (40.0) 7 (46.7) 0.68 11 (36.7) 6 (60.0) 0.196
 High 23 (57.5) 15 (60.0) 8 (53.3)   19 (63.3) 4 (40.0)  
p62 in ANT
 Low 24 (60.0) 15 (60.0) 9 (60.0) 0.99 20 (66.7) 4 (40.0) 0.136
 High 16 (40.0) 10 (40.0) 6 (40.0)   10 (33.3) 6 (60.0)  
  1. ANT: Adjacent non-tumor tissues